Amphastar Pharmaceuticals (AMPH) Return on Equity [ROE] (2014 - 2026)
Amphastar Pharmaceuticals' Return on Equity [ROE] came in at 10.19% for Q2 2026, down 7.67 percentage points from 17.86% a year earlier but up 0.05 percentage points from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Amphastar Pharmaceuticals' Return on Equity [ROE] was 12.90%, down 10.36 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +12.65 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 23.26% in FY2024 (-0.29 pp), 23.55% in FY2023 (+4.79 pp), 18.76% in FY2022 (+4.60 pp) and 14.16% in FY2021 (+13.91 pp).
- The five-year range for quarterly Return on Equity [ROE] is 8.41% (Q3 2021) to 24.03% (Q2 2024).
- Year-over-year, Return on Equity [ROE] has declined for eight consecutive quarters, with an average year-over-year change of -5.67 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2022 (a gain of 17.73 percentage points), and the weakest in Q4 2025 (a drop of 9.32 percentage points).
- Business Quant data shows AMPH's Return on Equity [ROE] at 10.14% (Q1 2026), 12.53% (Q4 2025) and 14.55% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Amphastar Pharmaceuticals | 1.10 Bn | -43.34 Mn | 93.47 Mn | 10.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.19% |
| Mar 31, 2026 | 10.14% |
| Dec 31, 2025 | 12.53% |
| Sep 30, 2025 | 14.55% |
| Jun 30, 2025 | 17.86% |
| Mar 31, 2025 | 19.09% |
| Dec 31, 2024 | 21.85% |
| Sep 30, 2024 | 21.89% |
| Jun 30, 2024 | 24.03% |
| Mar 31, 2024 | 23.58% |
| Dec 31, 2023 | 22.28% |
| Sep 30, 2023 | 22.85% |
| Jun 30, 2023 | 17.92% |
| Mar 31, 2023 | 17.30% |
| Dec 31, 2022 | 17.68% |
| Sep 30, 2022 | 15.38% |
| Jun 30, 2022 | 18.86% |
| Mar 31, 2022 | 18.07% |
| Dec 31, 2021 | 14.46% |
| Sep 30, 2021 | 8.41% |
API Access
Amphastar Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();